1 – 10 of 1021
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
(
- Contribution to journal › Article
-
Mark
In vitro characterisation of a novel rubber contact allergen in protective gloves
(
- Contribution to journal › Article
-
Mark
Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform
(
- Contribution to journal › Article
-
Mark
Altered immune signatures in breast cancer lymph nodes with metastases revealed by spatial proteome analyses
(
- Contribution to journal › Article
-
Mark
The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
(
- Contribution to journal › Article
-
Mark
Proteomic profiling reveals alterations in metabolic and cellular pathways in severe obesity and following metabolic bariatric surgery
(
- Contribution to journal › Article
-
Mark
Editorial : Allergen-specific antibodies: from basic science to clinical application
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
In vivo composition of the mitochondrial nucleoid in mice
(
- Contribution to journal › Article
- 2024
-
Mark
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
(
- Contribution to journal › Article
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
(
- Contribution to journal › Article